INNOVATE Corp. 2026 Q1 - Results - Earnings Call Presentation
INNOVATE Corp. Announces First Quarter 2026 Results
INNOVATE Corp. (VATE) Q1 2026 Earnings Call Prepared Remarks Transcript
Innovate Q1 2026 Earnings Call Transcript
Innovate Q1 EPS $(1.29) Up From $(1.89) YoY, Sales $364.800M Up From $274.200M YoY
INNOVATE Corp. to Report First Quarter 2026 Results on May 14th
INNOVATE’s Portfolio Company DBM Global to Pay Cash Dividend
INNOVATE To Pay Cash Dividend Of ~$3M, Or $0.78 Per Share, On April 28
INNOVATE Q4: MediBeacon Sale Could Be Only Saving Grace, Downgrade To Sell
DBM Global to Pay Cash Dividend
MediBeacon® Transdermal GFR Monitor and Reusable Sensor Receive CE Mark Under European Medical Device Regulation
INNOVATE Q4 Earnings Call Highlights
INNOVATE Corp. Announces Fourth Quarter and Full Year 2025 Results
INNOVATE Corp. (VATE) Q4 2025 Earnings Call Prepared Remarks Transcript
INNOVATE Corp. 2025 Q4 - Results - Earnings Call Presentation
Innovate Q4 EPS $(0.58) Up From $(1.29) YoY, Sales $382.700M Up From $236.600M YoY
INNOVATE Corp. to Report Fourth Quarter and Full Year 2025 Results on March 26th
Transdermal GFR Article Recognized as One of Five 2025 Editors’ Choice Articles by Journal of the American Society of Nephrology (JASN)
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.